Ads
related to: how often is tpn administered for lung cancer treatment- FAQs
Find Helpful Information & Terms
To Learn About Safety & Treatment.
- About NSCLC
Safety, Efficacy, & More Resources
For An NSCLC Treatment Option.
- Financial Assistance
Learn About Your Options That May
Help You Afford An NSCLC Treatment.
- Starting Treatment
Learn About the Infusion Process
And Flexible Dosing Schedule.
- Talk To Your Doctor
See Possible Questions To Ask Your
Doctor. Discuss Your Treatment Plan
- Treatment & Safety Info
Learn How Treatment Is Designed To
Work. Find Efficacy & Safety Info.
- FAQs
Search results
Results From The WOW.Com Content Network
Total parenteral nutrition (TPN) is provided when the gastrointestinal tract is nonfunctional because of an interruption in its continuity (it is blocked, or has a leak – a fistula) or because its absorptive capacity is impaired. [6] It has been used for comatose patients, although enteral feeding is usually preferable, and less prone to ...
Chemotherapy for NSCLC usually includes combination of two drugs (chemotherapy doublet), with one of the agents is cisplatin or carboplatin. In 2002, Schiller at al. published in the New England Journal of Medicine, a study that compared four chemotherapy regimens for advanced NSCLC, cisplatin and paclitaxel, cisplatin and gemcitabine, cisplatin and docetaxel, and carboplatin and paclitaxel. [14]
Lung cancer is responsible for 1.3 million deaths worldwide annually and is the most common cause of cancer-related death in men and the second most common in women. According to the World Health Organization, lung cancer was responsible for approximately 10 million deaths in 2020. [2]
Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [1] Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, [2] and PARP inhibitors such as olaparib. [3]
The term "induction regimen" refers to a chemotherapy regimen used for the initial treatment of a disease. A "maintenance regimen" refers to the ongoing use of chemotherapy to reduce the chances of a cancer recurring or to prevent an existing cancer from continuing to grow. [2]
Adenocarcinoma of the lung is currently the most common type of lung cancer in "never smokers" (lifelong nonsmokers). [10] Adenocarcinomas account for about 40% of lung cancers. Historically, adenocarcinoma was more often seen peripherally in the lungs than SCLC and squamous-cell lung cancer, both of which tended to be more often centrally located.
Ad
related to: how often is tpn administered for lung cancer treatment